Aldose reductase mediates the mitogenic signals of cytokines

Kota Ramana, Deepak Chandra, Sanjay Srivastava, Aruni Bhatnagar, Satish Srivastava

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Chronic hyperglycemia is associated with the activation of aldose reductase (AR), an increase in cytokines such as TNF-α and IL-8 and oxidative stress. Alterations in this interdependent cascade of signals may be responsible for the diabetes-induced increase in the incidence and severity of cardiovascular diseases such as atherosclerosis and hypertension. We have previously shown that inhibition of AR prevents cultured vascular smooth muscle cell (VSMC) growth and restenosis of balloon-injured carotid arteries. To identify the mechanisms by which inhibition of AR prevents cell growth, we examined the effects of AR inhibition on mitogenic signaling by cytokines. Stimulation with TNF-α led to the activation of the transcription factor NF-κB and enhanced VSMC growth. Treatment with the AR inhibitors sorbinil or tolrestat, attenuated mitogen-induced activation of NF-κB and VSMC proliferation. In cultured VSMC, AR inhibitors prevented signaling events upstream of NF-κB activation, i.e. IκB-α phosphorylation and IκB-α degradation. Inhibition of AR also prevented protein kinase C (PKC) activation by TNF-α, but did not affect PKC activation by phorbol esters, indicating that inhibition of AR interrupts mitogenic signaling upstream of PKC. Together, these results indicate a pivotal role of AR or its reaction product(s) in the mitogenic signals initiated by cytokines that are elevated in diabetes and its cardiovascular complications such as atherosclerosis. These observations suggest a possible therapeutic use of AR inhibitors in these pathological conditions.

Original languageEnglish (US)
Pages (from-to)587-596
Number of pages10
JournalChemico-Biological Interactions
Volume143-144
DOIs
StatePublished - Feb 1 2003

Fingerprint

Aldehyde Reductase
Cytokines
Chemical activation
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Cell growth
Protein Kinase C
Medical problems
Atherosclerosis
Growth
Phosphorylation
Oxidative stress
Balloons
Cell proliferation
Phorbol Esters
Therapeutic Uses
Interleukin-8
Reaction products
Mitogens

Keywords

  • Aldose reductase
  • Cell growth
  • Smooth muscle cell
  • Sorbinil
  • TNF-α

ASJC Scopus subject areas

  • Toxicology

Cite this

Aldose reductase mediates the mitogenic signals of cytokines. / Ramana, Kota; Chandra, Deepak; Srivastava, Sanjay; Bhatnagar, Aruni; Srivastava, Satish.

In: Chemico-Biological Interactions, Vol. 143-144, 01.02.2003, p. 587-596.

Research output: Contribution to journalArticle

Ramana, K, Chandra, D, Srivastava, S, Bhatnagar, A & Srivastava, S 2003, 'Aldose reductase mediates the mitogenic signals of cytokines', Chemico-Biological Interactions, vol. 143-144, pp. 587-596. https://doi.org/10.1016/S0009-2797(02)00194-1
Ramana, Kota ; Chandra, Deepak ; Srivastava, Sanjay ; Bhatnagar, Aruni ; Srivastava, Satish. / Aldose reductase mediates the mitogenic signals of cytokines. In: Chemico-Biological Interactions. 2003 ; Vol. 143-144. pp. 587-596.
@article{9638f6710d97432b871ecc78a8118227,
title = "Aldose reductase mediates the mitogenic signals of cytokines",
abstract = "Chronic hyperglycemia is associated with the activation of aldose reductase (AR), an increase in cytokines such as TNF-α and IL-8 and oxidative stress. Alterations in this interdependent cascade of signals may be responsible for the diabetes-induced increase in the incidence and severity of cardiovascular diseases such as atherosclerosis and hypertension. We have previously shown that inhibition of AR prevents cultured vascular smooth muscle cell (VSMC) growth and restenosis of balloon-injured carotid arteries. To identify the mechanisms by which inhibition of AR prevents cell growth, we examined the effects of AR inhibition on mitogenic signaling by cytokines. Stimulation with TNF-α led to the activation of the transcription factor NF-κB and enhanced VSMC growth. Treatment with the AR inhibitors sorbinil or tolrestat, attenuated mitogen-induced activation of NF-κB and VSMC proliferation. In cultured VSMC, AR inhibitors prevented signaling events upstream of NF-κB activation, i.e. IκB-α phosphorylation and IκB-α degradation. Inhibition of AR also prevented protein kinase C (PKC) activation by TNF-α, but did not affect PKC activation by phorbol esters, indicating that inhibition of AR interrupts mitogenic signaling upstream of PKC. Together, these results indicate a pivotal role of AR or its reaction product(s) in the mitogenic signals initiated by cytokines that are elevated in diabetes and its cardiovascular complications such as atherosclerosis. These observations suggest a possible therapeutic use of AR inhibitors in these pathological conditions.",
keywords = "Aldose reductase, Cell growth, Smooth muscle cell, Sorbinil, TNF-α",
author = "Kota Ramana and Deepak Chandra and Sanjay Srivastava and Aruni Bhatnagar and Satish Srivastava",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S0009-2797(02)00194-1",
language = "English (US)",
volume = "143-144",
pages = "587--596",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Aldose reductase mediates the mitogenic signals of cytokines

AU - Ramana, Kota

AU - Chandra, Deepak

AU - Srivastava, Sanjay

AU - Bhatnagar, Aruni

AU - Srivastava, Satish

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Chronic hyperglycemia is associated with the activation of aldose reductase (AR), an increase in cytokines such as TNF-α and IL-8 and oxidative stress. Alterations in this interdependent cascade of signals may be responsible for the diabetes-induced increase in the incidence and severity of cardiovascular diseases such as atherosclerosis and hypertension. We have previously shown that inhibition of AR prevents cultured vascular smooth muscle cell (VSMC) growth and restenosis of balloon-injured carotid arteries. To identify the mechanisms by which inhibition of AR prevents cell growth, we examined the effects of AR inhibition on mitogenic signaling by cytokines. Stimulation with TNF-α led to the activation of the transcription factor NF-κB and enhanced VSMC growth. Treatment with the AR inhibitors sorbinil or tolrestat, attenuated mitogen-induced activation of NF-κB and VSMC proliferation. In cultured VSMC, AR inhibitors prevented signaling events upstream of NF-κB activation, i.e. IκB-α phosphorylation and IκB-α degradation. Inhibition of AR also prevented protein kinase C (PKC) activation by TNF-α, but did not affect PKC activation by phorbol esters, indicating that inhibition of AR interrupts mitogenic signaling upstream of PKC. Together, these results indicate a pivotal role of AR or its reaction product(s) in the mitogenic signals initiated by cytokines that are elevated in diabetes and its cardiovascular complications such as atherosclerosis. These observations suggest a possible therapeutic use of AR inhibitors in these pathological conditions.

AB - Chronic hyperglycemia is associated with the activation of aldose reductase (AR), an increase in cytokines such as TNF-α and IL-8 and oxidative stress. Alterations in this interdependent cascade of signals may be responsible for the diabetes-induced increase in the incidence and severity of cardiovascular diseases such as atherosclerosis and hypertension. We have previously shown that inhibition of AR prevents cultured vascular smooth muscle cell (VSMC) growth and restenosis of balloon-injured carotid arteries. To identify the mechanisms by which inhibition of AR prevents cell growth, we examined the effects of AR inhibition on mitogenic signaling by cytokines. Stimulation with TNF-α led to the activation of the transcription factor NF-κB and enhanced VSMC growth. Treatment with the AR inhibitors sorbinil or tolrestat, attenuated mitogen-induced activation of NF-κB and VSMC proliferation. In cultured VSMC, AR inhibitors prevented signaling events upstream of NF-κB activation, i.e. IκB-α phosphorylation and IκB-α degradation. Inhibition of AR also prevented protein kinase C (PKC) activation by TNF-α, but did not affect PKC activation by phorbol esters, indicating that inhibition of AR interrupts mitogenic signaling upstream of PKC. Together, these results indicate a pivotal role of AR or its reaction product(s) in the mitogenic signals initiated by cytokines that are elevated in diabetes and its cardiovascular complications such as atherosclerosis. These observations suggest a possible therapeutic use of AR inhibitors in these pathological conditions.

KW - Aldose reductase

KW - Cell growth

KW - Smooth muscle cell

KW - Sorbinil

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=19244385545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244385545&partnerID=8YFLogxK

U2 - 10.1016/S0009-2797(02)00194-1

DO - 10.1016/S0009-2797(02)00194-1

M3 - Article

VL - 143-144

SP - 587

EP - 596

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

ER -